XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.25.3

WARRANTS TO PURCHASE COMMON STOCK | 9 Months Ended
--- | ---
Sep. 30, 2025
Warrants To Purchase Common Stock |
WARRANTS TO PURCHASE COMMON STOCK | NOTE 15 – WARRANTS TO PURCHASE COMMON STOCK The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company at September 30, 2025:
Exercise |  |  | Number |  |  | Expiration |
Price |  |  | Outstanding |  |  | Date |
$ | 1,056.00 |  |  |  | 4,585 |  |  | April 2029 |
$ | 1,056.00 |  |  |  | 2,782 |  |  | April 2029 |
$ | 1,056.00 |  |  |  | 2,172 |  |  | April 2029 |
$ | 1,056.00 |  |  |  | 10,884 |  |  | April 2029 |
$ | 1,600.00 |  |  |  | 36 |  |  | October 2028 |
$ | 2,720.00 |  |  |  | 5,758 |  |  | December 2028 |
$ | 3,200.00 |  |  |  | 22 |  |  | August 2028 |
|  |  |  |  | 26,239 |  |  |  |
During the nine months ended September 30, 2025, 13,666; 5,758 (as the Company received FDA acceptance of our NDA filing), and 1 warrants with an exercise price of $1,056, $1,776 and $364,800, respectively, expired. During the nine months ended September 30, 2024, 113,155 prefunded common warrants were exercised.

X
- References No definition available. + Details
Name: | tnxp_DisclosureWarrantsToPurchaseCommonStockAbstract
Namespace Prefix: | tnxp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of stock warrants. + References No definition available. + Details
Name: | tnxp_StockWarrantsTextBlock
Namespace Prefix: | tnxp_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration